Familes Blast GSK's New Zofran Label Submission In MDL
Families in multidistrict litigation over GlaxoSmithKline's anti-nausea drug Zofran on Thursday told a Massachusetts federal court that a 2016 label update shows that it was, in fact, possible to show additional...To view the full article, register now.
Already a subscriber? Click here to view full article